Product News
Revolutionising Nanoparticle Production: Technical Evaluation Introduces Cutting-Edge Formulation Technology
In a significant stride towards advancing nanoparticle drug delivery manufacturing technology, German pharmatech company, leon-nanodrugs GmbH (LEON), proudly announces a pioneering technical evaluation by CMAC, University of Strathclyde.
Product News
Metrion Biosciences Enhances High Throughput Screening Services With Access to Enamine Compound Libraries
Access to compound collection enables greater flexibility and efficiencies in screening and target identification.
Product News
University of Liverpool To Use Touchlight’s Rapid Enzymatic dbDNA in Fully Personalised Neoantigen Cancer Vaccine Clinical
The UK’s Medical Research Council is funding a 10-patient Phase I study to deliver rapid personalised treatment for lung cancer patients.
Product News
Therapeutic Potential of CD20 X CD3 Bispecific Antibodies
As of March 2024, the FDA has approved three CD20 × CD3 BsAbs: mosunetuzumab (Lunsumio) for relapsed or refractory follicular lymphoma (R/R FL), glofitamab (Columvi) for relapsed or refractory diffuse B cell lymphoma
Product News
Sino Biological Announces Services Partnership With Rapid Novor
Sino Biological and Rapid Novor partner to offer combined antibody development and sequencing services.
Product News
InSphero and PharmaNest Unveil a Promising Tool for MASH Drug Discovery
InSphero's Liver Disease team has published a groundbreaking peer-reviewed paper in Nature's Scientific Reports, challenging the limitations of in vitro models in MASH Drug Discovery.
Product News
ProBioGen Partners With MAPP BIOPHARMACEUTICAL, INC. for Groundbreaking Development of Afucosylated Antibody Against Marburg Virus Disease
ProBioGen, is pleased to announce the execution of services and license agreements with MAPP BIOPHARMACEUTICAL, INC. to develop a cell line for an afucosylated antibody targeting Marburg virus (MARV) infection.
Product News
Noramco Announces Strategic Alignment With Purisys and Halo Pharma, Launching the Noramco Group
The Noramco group addresses critical supply chain challenges, offering comprehensive active pharmaceutical ingredients (API) and drug product solutions.
Product News
BioSenic Releases Details of Optimized Administration Approach Ahead of Planned Phase 3 Trial of OATO
New data builds on earlier findings from a post-hoc Phase 2 analysis that helped reposition BioSenic’s oral arsenic trioxide (OATO) program for pivotal trials.
Product News
LGM Pharma Unveils Enhanced Analytical Testing Services and Expands CDMO Portfolio
Growth of suppository manufacturing capabilities addresses increasing market demand to meet the needs
of geriatric and pediatric patients, and women’s health.
of geriatric and pediatric patients, and women’s health.
Advertisement